BioMarin Pharmaceutical Inc(NASDAQ:BMRN) 
BioMarin Pharmaceutical Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Aldurazyme to treat mucopolysaccharidosis I, a genetic disease; Brineura for the treatment o...
Website: http://www.biomarin.com
Founded: 1997
Full Time Employees: 3,001
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 66.25
H 66.49
L 59.99
C 60.26
V 3,544,954
10EMA 60.26
20EMA 60.26
60EMA 60.26
120EMA 60.26
250EMA 60.26